Monday Dec 16, 2024
Wednesday, 11 November 2015 00:02 - - {{hitsCtrl.values.hits}}
Hemas Manufacturing Managing Director Roy Joseph exchanges the signed agreement with SLINTEC CEO Harin de Silva Wijeyeratne on 15 October. Also present from left: Hemas Director Innovation and New Business Dr. Himesh Fernando, Manager Legal Maheshi Pieries, Head of Corporate Finance Vathsala Wijekoon, Director R&D Dimuthu Jayasinghe, Science Team Leader Prof. Nalin de Silva and representing the Business Development Team, Rashmi Wijekoon
The Sri Lanka Institute of Nanotechnology (SLINTEC) and Hemas Manufacturing Ltd. have entered into a research agreement to expand the Hemas’ personal care product portfolio by adding a revitalising skin care solution with scientifically proven efficacy.
SLINTEC is a public-private partnership between the Government of Sri Lanka and major players in the private sector; namely MAS Holdings, Brandix, Dialog, Hayleys, Loadstar and Lankem. SLINTEC is committed to assist the local industries in improving and developing products and processes to meet the demands of the local and international markets using nanotechnology and other advanced technology solutions.
Hemas Manufacturing Ltd. is one of the key subsidiaries of Hemas Group and is driven by innovative brands such as Velvet, Kumarika, Baby Cheramy, and Clogard that have evolved to become household names. The Group has accelerated its growth strategies within its core business areas whilst developing an innovative culture for future growth. The Hemas Group is one of the leading conglomerates in Sri Lanka with a focus on four key sectors, namely Fast Moving Consumer Goods, Healthcare, Transportation, and Leisure.